175 related articles for article (PubMed ID: 34840219)
1. Cytological Assessment of Desmoplastic Malignant Pleural Mesothelioma in an Autopsy Case.
Kawamoto Y; Kure S; Katayama H; Kawahara K; Teduka K; Kunugi S; Onda M; Motoda N; Ohashi R
J Nippon Med Sch; 2023 Feb; 89(6):616-622. PubMed ID: 34840219
[TBL] [Abstract][Full Text] [Related]
2. [An autopsy case of desmoplastic malignant mesothelioma].
Nakagomi T; Kitada O; Nakamura H; Miyata S; Aragane K; Kodama T; Kuribayashi K; Jin S; Takenaka N; Nagasawa N; Sugita M
Nihon Kokyuki Gakkai Zasshi; 2002 Aug; 40(8):697-702. PubMed ID: 12428402
[TBL] [Abstract][Full Text] [Related]
3. Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma.
Yoshida M; Jimbo N; Tsukamoto R; Itoh T; Kawahara K; Mitsui S; Tanaka Y; Maniwa Y
Diagn Pathol; 2023 Nov; 18(1):126. PubMed ID: 38017544
[TBL] [Abstract][Full Text] [Related]
4. [Pleural effusion cytology of asbestos-associated malignant mesothelioma and lung carcinoma in the diagnosis of occupational diseases by the statutory accident insurance funds].
Biesterfeld S; Schramm M; Schad A; Pomjanski N
Pneumologie; 2014 Apr; 68(4):270-6. PubMed ID: 24615665
[TBL] [Abstract][Full Text] [Related]
5. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
6. 5-hmC loss is another useful tool in addition to BAP1 and MTAP immunostains to distinguish diffuse malignant peritoneal mesothelioma from reactive mesothelial hyperplasia in peritoneal cytology cell-blocks and biopsies.
Alsugair Z; Kepenekian V; Fenouil T; Glehen O; Villeneuve L; Isaac S; Hommell-Fontaine J; Benzerdjeb N
Virchows Arch; 2022 Jul; 481(1):23-29. PubMed ID: 35575935
[TBL] [Abstract][Full Text] [Related]
7. [A case of desmoplastic malignant mesothelioma with elevated serum CYFRA 21-1].
Nakamura H; Kitada O; Aragane K; Miyata S; Kodama T; Kuribayashi K; Nakagomi T; Takenaka N; Jin S; Nagasawa M; Sugita M
Nihon Kokyuki Gakkai Zasshi; 2002 Apr; 40(4):337-40. PubMed ID: 12096506
[TBL] [Abstract][Full Text] [Related]
8. The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey.
Paintal A; Raparia K; Zakowski MF; Nayar R
Cancer Cytopathol; 2013 Dec; 121(12):703-7. PubMed ID: 24039177
[TBL] [Abstract][Full Text] [Related]
9. Detailed clinical course of a patient with rapidly progressing sarcomatoid pleural mesothelioma without p16 deletion with systemic haematogenous metastasis to soft tissues.
Mizuhashi K; Okamoto K; Nabeshima K; Kishimoto T
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38341199
[TBL] [Abstract][Full Text] [Related]
10. An autopsy case of malignant pleural mesothelioma associated with nephrotic syndrome.
Suzuki S; Toyoshima M; Nihashi F; Tsukui H; Baba S; Sugimura H; Suda T
Intern Med; 2014; 53(3):243-6. PubMed ID: 24492694
[TBL] [Abstract][Full Text] [Related]
11. The cytological features of effusions with mesothelioma in situ: A report of 9 cases.
Michael CW; Bedrossian CCWM; Sadri N; Klebe S
Diagn Cytopathol; 2023 Jun; 51(6):374-388. PubMed ID: 36942732
[TBL] [Abstract][Full Text] [Related]
12. Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue.
Hida T; Matsumoto S; Hamasaki M; Kawahara K; Tsujimura T; Hiroshima K; Kamei T; Taguchi K; Iwasaki A; Oda Y; Honda H; Nabeshima K
Cancer Sci; 2015 Nov; 106(11):1635-41. PubMed ID: 26291840
[TBL] [Abstract][Full Text] [Related]
13. Adenomatoid mesothelioma with intranuclear inclusion bodies: a case report with cytological and histological findings.
Kawai T; Kawashima K; Serizawa H; Miura H; Kyeongil K
Diagn Cytopathol; 2014 May; 42(5):436-40. PubMed ID: 23166110
[TBL] [Abstract][Full Text] [Related]
14. The role of cytological evaluation of pleural fluid in diagnosing malignant mesothelioma.
Lovrenski A; Panjković M; Tegeltija D; Latinović LT; Krcedinac J
Med Pregl; 2012; 65(1-2):5-8. PubMed ID: 22452231
[TBL] [Abstract][Full Text] [Related]
15. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma.
Sherman ME; Mark EJ
Arch Pathol Lab Med; 1990 Aug; 114(8):845-51. PubMed ID: 2375659
[TBL] [Abstract][Full Text] [Related]
16. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.
Flores-Staino C; Darai-Ramqvist E; Dobra K; Hjerpe A
Lung Cancer; 2010 Apr; 68(1):39-43. PubMed ID: 19523712
[TBL] [Abstract][Full Text] [Related]
17. Genomic-based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma.
Kinoshita Y; Hamasaki M; Matsumoto S; Yoshimura M; Sato A; Tsujimura T; Kamei T; Kawahara K; Nabeshima K
Pathol Int; 2020 Sep; 70(9):671-679. PubMed ID: 32542810
[TBL] [Abstract][Full Text] [Related]
18. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.
Kinoshita Y; Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Hiroshima K; Oda Y; Nabeshima K
Cancer Cytopathol; 2018 Jan; 126(1):54-63. PubMed ID: 29053210
[TBL] [Abstract][Full Text] [Related]
19. A Rare Presentation of Minimally Invasive Mesothelioma as a Large Tension Pneumothorax.
Marshall T; Lane J; Lahorra J
Int J Surg Pathol; 2024 Feb; 32(1):109-114. PubMed ID: 37128670
[TBL] [Abstract][Full Text] [Related]
20. [Chronic pleuropathy due to asbestos and malignant mesothelioma of the pleura: a differential diagnosis not always easy. A case report].
de Pangher Manzini V
Recenti Prog Med; 1999 Jun; 90(6):331-3. PubMed ID: 10399473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
